Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands
- 17 February 2006
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 56 (1) , 101-109
Abstract
In recent years, studies on the molecular and cellular mechanisms of immune responses against melanoma have contributed to a better understanding of how these tumours can be recognised by cytotoxic cells and the mechanisms they have developed to escape from innate and adaptive immunity. Lysis of melanoma cells by natural killer (NK) cells and cytolytic T cells is the result of a fine balance between signals transmitted by activating and inhibitory receptors. In addition to the T cell receptor, these were initially described as NK cell-associated receptors (NKRs) and were later also found on subsets of T lymphocytes, particularly effector-memory and terminally differentiated CD8 T cells. An increase of NKR+CD8+ T cells has been found in melanoma patients, correlating with the expansion of differentiated effector CD8+CD28null CD27null T cells. NKRs can regulate the lysis of target cells expressing appropriate ligands. Activating receptors recognise ligands on tumours whereas inhibitory receptors are specific for MHC class I antigens and sense missing self. Altered expression of MHC class I antigens is frequently found on melanoma cells, preventing recognition by specific cytolytic T cells but favouring NK cell recognition. Changes in the expression of NKR-ligands in melanoma contribute in explaining the differences in the capacity of cytotoxic immune cells to control melanoma growth and dissemination.Keywords
This publication has 99 references indexed in Scilit:
- Immunotherapy: target the stroma to hit the tumorTrends in Molecular Medicine, 2005
- The LLT1 receptor induces IFN-γ production by human natural killer cellsMolecular Immunology, 2004
- Immune functions encoded by the natural killer gene complexNature Reviews Immunology, 2003
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- Human NK-cell receptorsImmunology Today, 2000
- How much longer will tumour cells fool the immune system?Immunology Today, 2000
- Paired inhibitory and triggering NK cell receptors for HLA class I moleculesHuman Immunology, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.Journal of Clinical Investigation, 1991
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990